可耕种
发表于 2025-3-25 06:09:46
https://doi.org/10.1007/978-94-009-6798-4antibiotics; cancer; chemotherapy; metabolism; research; tumor
配偶
发表于 2025-3-25 07:40:26
http://reply.papertrans.cn/89/8803/880279/880279_22.png
谷类
发表于 2025-3-25 13:21:54
http://reply.papertrans.cn/89/8803/880279/880279_23.png
Astigmatism
发表于 2025-3-25 18:22:33
Book 1983of cancer, aiming to improve prognosis of the cancer patient. For almost a century, surgery has now been the main treatment modality for the cancer patient. During the past 50 years radiation therapy has developed as a second important modality of treatment. However, neither of the two modalities ar
HEAVY
发表于 2025-3-25 22:25:06
Introduction,tient. During the past 50 years radiation therapy has developed as a second important modality of treatment. However, neither of the two modalities are able to cure the majority of cancer patients, as the disease is so often metastasized at presentation.
冰雹
发表于 2025-3-26 03:22:05
Structure-Activity Relationships among Antitumour Quinones,iamycin, mitomycin C, streptonigrin, lapachol, trenimon and carbazilquinone. New quinoid compounds currently under investigation by the National Cancer Institute (NCI) in the United States are AZQ, dihydroxyanthracenedione, aclacinomycin A and 7-OMEN.
词汇
发表于 2025-3-26 08:10:02
In Vitro Oxidative Activation: A Model for the Cytotoxic Action of 9-Hydroxy Ellipticine Derivativeellipticine (9-OH-E) leads to a compound, N2-methyl 9-hydroxy ellipticinium (NSC 264137) (9-OH-NME+) which is one of the most efficient anticancer drug in these series (3) and has been retained for clinical use in humans (4).
frenzy
发表于 2025-3-26 09:48:43
DTIC: A Springboard to New Antitumour Agents, DTIC as there are chemists and biochemists who, ensnared by the apparent deceptive simplicity of the molecule, have responded to the challenge but abjectly failed in the task of unravelling its perverse secrets.
Exonerate
发表于 2025-3-26 15:20:11
http://reply.papertrans.cn/89/8803/880279/880279_29.png
啤酒
发表于 2025-3-26 17:44:13
http://reply.papertrans.cn/89/8803/880279/880279_30.png